Parkinson’s UK has today (15 January) revealed updated branding, including a new logo and strapline, and a bespoke accessible font. The changes seek to make the brand more visible, accessible and ...

Unifying community building, raising awareness and promoting professional research under one brand is a challenge Parkinson’s UK tackled head on with its recent brand refresh. The revamp is the latest ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

Parkinson's UK reports that an estimated 153,000 people in the UK currently live with Parkinson's, which is the fastest-growing neurological condition in the world. There may be a link between ...

according to Parkinson’s UK – a leading charity researching the illness. Muhammad Ali Jr. in the UK last year (Pic: Derek Marshall) In the UK, around 153,000 people are already living with ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK Media Enrollment ... of moderate-stage Parkinson’s disease Phase Ib 36-month data ...

David Dexter, deputy director of research at Parkinson's UK, highlighted at the time: "Genetic forms of Parkinson's account for approximately 8 per cent of individuals receiving a Parkinson's ...

The production will include both active and placebo batches for the Parkinson’s study. This manufacturing initiative will be conducted under current Good Manufacturing Practices (CGMP ...